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Introduction
Cigarette smoking (CS) is an established risk factor for the 
inception of chronic obstructive pulmonary disease (COPD), 
which is pathologically characterized by pulmonary tissue 
damage manifested by airspace enlargement and excessive 
collagen deposition in the small airways of <2 mm in diam-
eter, termed airway remodeling
[1, 2].  It has become apparent 
that these two pathological alterations can be found in many 
patients with COPD
[2].  Niewoehner and coworkers dem-
onstrated that early structural changes in the small airways 
existed even before the establishment of COPD
[3].  Subsequent 
studies consistently showed that small airway remodeling was 
pivotal in causing airflow limitation in patients with COPD
[4–6].   
However, the underlying mechanisms of remodeling remain 
unclear.
The roles of chemokines via their respective receptors in 
the pathogenesis of COPD have been extensively addressed 
elsewhere
[7–9].  For example, CXCL9, and CXCL10, and CXCL11 
and CCL5, ligands for CXCR3 and CCR5, respectively, were 
shown to be elevated in sputum from COPD patients
[10].  An 
antagonist of CXCR2 has been shown to abrogate lung neutro-
philic inflammation in rodent models of CS exposure
[11].  Lung 
tissue inflammation and emphysema induced by CS were 
significantly decreased in both CCR5-/- and CCR6-/- mice 
through the decreased release of macrophage inflammatory 
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Aim: To investigate the role of chemokine receptor CXCR3 in cigarette smoking (CS)-induced pulmonary damage. 
Methods:  CXCR3 knockout (CXCR3-/-) mice were used. Differences in airspace enlargement, mRNA expression of matrix metalloprotei-
nases (MMPs), transforming growth factor (TGF) β1, CXCL10 in lung homogenates, and CXCL10 content in bronchoalveolar lavage (BAL) 
fluids and homogenates were compared between CXCR3-/- mice and wild-type (WT) mice three days after three-day CS exposures.
Results: The linear intercept was significantly less in CXCR3-/- mice than in WT mice (30.1±0.9 µm vs 40.3±2.4 µm, P<0.01).  Morpho-
logically, collagen was deposited less around airways and vessels in CXCR3-/- mice.  The lung hydroxyproline content was significantly 
lower in CXCR3-/- mice than in WT mice (6.0±1.0 µg/mL vs 12.0±1.6 µg/mL, P<0.05).  Profoundly lower mRNA expression of MMP2, 
MMP12, TGFβ1, and CXCL10 was seen in lung homogenates from CXCR3-/- mice.  CXCL10 concentrations in BAL fluid and lung homo-
genates were significantly lower in CXCR3-/- mice than in WT mice (BAL fluid: 19.3±1.4 pg/mL vs 24.8±1.6 pg/mL, P<0.05; lung homo-
genates: 76.6±7.0 pg/mL vs 119.5±15.9 pg/mL, P<0.05).  
Conclusion: CXCR3 is important in mediating lung tissue damage and airway remodeling following a short-term CS insult, possibly 
through up-regulation of CXCL10 and inducement of mRNA expression of MMPs.  Targeting CXCR3 may be helpful for prevention of CS-
induced pulmonary pathology.
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proteins: (MIP)-1α, MIP-1β, CXCL10, and MIP-3α
[7, 8].
Accumulating evidence has suggested that CXCR3-CXCL10 
interactions play a pivotal role in the inception and progres-
sion of COPD via recruitment of CD8+ T cells into airways 
and lung parenchyma
[12, 13].  CXCR3 and its specific ligand 
CXCL10/interferon-inducible protein-10 (IP-10) were abun-
dantly expressed in bronchiolar epithelial cells and airway 
smooth muscle cells.  CD8+ T cells expressing CXCR3 in 
epithelium and submucosa in smokers with COPD were 
increased
[14].  Our recent studies documented that CXCR3 is 
involved in acute pulmonary inflammation induced by short-
term exposure of CS through recruitment of CD8+ T cells into 
lung and in the release of CXCL10/interferon γ-inducible pro-
tein (IP)-10
[15, 16].  Given the importance of CXCR3 in attract-
ing inflammatory cells into lung, we thus hypothesized that 
CXCR3 and CXCL10/IP-10 might be important for the pulmo-
nary damage induced by short-term exposure to CS, in par-
ticular, lung connective tissue breakdown and airway remod-
eling.  We have addressed this hypothesis by using CXCR3 
knockout mice exposed to CS for three consecutive days.
Materials and methods
Mice and cigarette smoke exposure
Mice deficient in the CXCR3 gene have been established by 
gene targeting as described elsewhere
[17].  CXCR3 KO mice 
and WT littermate mice (Experimental Animal Research Cen-
ter, Beijing, China) with C57BL/6 background (backcross >14 
generations) were maintained in a pathogen-free mouse facil-
ity at the Peking Union Medical College Animal Care Center.   
Clean food and water were supplied with free access.  Mice 
aged 10–12 weeks (about 20–22 g in weight) were used in the 
experiments.  
A commercially available filter cigarette was used (White 
Shark brand, Hunan Tobacco Company, China) and, according 
to the manufacturer’s specification, each cigarette contained 1 
mg of nicotine and 13 mg of tar.  CS exposure was performed 
according to previously described pro  tocols
[15, 16, 18, 19].  Briefly, 
the mice (n=8 per group) were placed in a closed plastic box 
connected to a smoke generator, and they received whole-
body exposure to the tobacco smoke of five cigarettes four 
times a day with 30-min smoke free intervals for three con-
secutive days.  Control mice received filtered air according to 
the same procedure.  Animals were sacrificed three days after 
the last CS exposure by pentobarbital overdose.
All experiments were conducted according to international 
and institutional guidelines for animal care and approved by 
Peking Union Medical College Hospital Committee on the 
Animal Care and Use.
Histological analysis of lung tissue 
The mice were killed, and the lungs were inflated with 25 mL 
H2O with 10% formalin and fixed overnight, embedded in par-
affin, and sectioned at 5 µmol/L.  The sections were stained 
with hematoxylin and eosin for routine histology examined 
by light microscopy.  Mature collagen deposited around small 
airways and vessels was stained using the standard Masson 
trichrome method.  
The mean linear intercept (Lm), which is the average dis-
tance between alveolar walls, reflects enlargement of alveolar 
spaces.  Quantification of Lm was done by light microscopy by 
two blinded investigators according to previously described 
methods
[7, 8].  Briefly, the Lm was measured by placing a 
100×100-µm grid on each field.  The total length of each line of 
the grid divided by the number of alveolar intercepts gener-
ates the average distance between alveolated surfaces.  His-
topathological assessment on small airway remodeling and 
inflammatory response in the lung was performed in a blind 
manner by Dr Wei-xun ZHOU.
Bronchoalveolar lavage (BAL) and lung homogenates 
Mice were sacrificed, and the tracheas were cannulated by 
using a 20-gauge catheter.  BAL was performed twice with 0.8 
mL of ice-cold PBS (pH 7.4) each.  The BAL fluid was spun at 
1500 rpm for 5 min at 4 
oC, and the supernatant was collected 
and stored at -70 
oC until analyzed.  
Animals were euthanized and perfused with 3 mL of cold 
saline via the heart.  The left lobes were removed and homog-
enized in 1 mL of PBS containing a complete protease inhibi-
tor cocktail (Sigma).  Then, the samples were centrifuged for 
10 min at 3000 rpm.  Supernatants were filtered through a 
0.45-µm filter and kept at -70 
oC until used.
Hydroxyproline assay 
Total lung collagen was determined by analysis of hydroxy-
proline as previously described with minor modification
[20].   
Briefly, lungs were harvested at three days after CS exposure 
and homogenized in 2 mL of PBS (pH 7.4).  A dose of 0.5 mL 
of each sample was then digested with 0.5 mL of 12 mol/L 
HCl at 120 
oC overnight.  5 µL of citrate/acetate buffer (5% 
citric acid, 7.24% sodium acetate, 3.4% sodium hydroxide, 
and 1.2% glacial acetic acid, pH 6.0) and 100 µL of chlomine-
T solution (282 mg chloramines-T, 2 mL n-propanol, 2 mL 
H2O, and 16 mL citrate/acetate buffer) were added to 5 µL of 
the sample at room temperature for 20 min.  Then 100 µL of 
Ehrlich’s solution [2.5 g 4-(dimethylamine) benzaldehyde, 9.3 
mL n-propanol, and 3.9 mL 70% perchloric acid] were added 
to each sample, and the samples were incubated for 15 min at 
65 
oC.  Samples were cooled to room temperature and read at 
550 nm.  Hydroxyproline standards (Sigma) at concentrations 
from 0 to 50 µg/mL were used to construct a standard curve.
Determination of protein content in BAL fluid 
Total protein content in BAL fluid was assayed using the BCA 
Protein Assay Kit (Pierce) according to the manufacturer’s 
instructions.
ELISA analysis of TNFα and CXCL10 in BAL fluid
The concentrations of TNFα and CXCL10 in BAL fluid and/or 
lung homogenates were determined by ELISA kits (R&D sys-
tems) according to the manufacturer’s recommendations.438
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RNA extraction and semi-quantitative RT-PCR analysis
Total RNA was extracted from the lung using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instructions 
and treated with RNase-free DNase.  RNA was reverse-tran-
scribed, and cDNA was subjected to PCR for analyzing the 
expression of IFNγ, CXCL9, CXCL10, CXCL11, metallopro-
teinases (MMP-2, MMP-9, and MMP-12), a tissue inhibitor of 
metalloproteinases (TIMPs)1–4, and β-actin.  The primers for 
the PCR are detailed in Table 1.
Statistical analysis
Data are expressed as mean±SEM.  Where appropriate, com-
parisons among groups were carried out using ANOVA 
followed by an unpaired Student’s t-test (two-tailed) using 
GraphPad PRISM software (Version 4.0 for Windows; Graph-
Grad, San Diego, CA).  A value of P<0.05 was set as the thresh-
old for significance.
 
Results
CS-induced airspace enlargement is partially alleviated in 
CXCR3-/- mice
Destruction of intricate alveolar architecture is manifested 
by enlarged alveolar spaces
[21].  To evaluate the difference in 
enlargement of alveolar spaces between CXCR3-/- mice and 
WT mice after short-term CS insult, we measured the linear 
intercept, Lm, which reflects the average distance between 
alveolar walls and parallels the degree of emphysema
[12].
No obvious inflammation response was noted in CXCR3-/- 
mice; in contrast, CXCR3-/- mice displayed significant alle-
viation of airspace enlargement in comparison to CXCR3 WT 
mice at three days after the last CS exposure (Figure 1A).  Lm 
values were significantly reduced in CXCR3-/- mice com-
pared to CXCR3 WT mice (30.1±0.9 µm vs 40.3±2.4 µm, P<0.01, 
Figure 1B).
CXCR3 is required for mRNA expression of MMPs in lung 
homogenates upon CS exposure
Lung tissue change is thought to be due to a protease-anti-
protease imbalance that favors proteases.  Elastin-degrading 
enzymes, such as MMP2, MMP9, and MMP12, have the capa-
bility of facilitating lung destruction
[22, 23].  At three days after 
short-term CS exposure, there was significantly decreased 
mRNA expression of MMP2 and MMP12, but not MMP9, in 
lung homogenates from CXCR3-/- mice relative to CXCR3 
WT mice (Figure 2A).  In contrast, there was significant eleva-
tion of TIMP3 mRNA expression in lung homogenates from 
CXCR3-/- mice at three days after the final CS exposure 
(Figure 2B).
CXCL10 at mRNA and protein levels was decreased in CXCR3-/- 
mice 
As shown in Figure 3A, mRNA expression of CXCL10, but not 
Figure 1.  Effect of CXCR3 deletion on airspace enlargement at three 
days after the last CS exposure.  (A) Morphometrical appearance of lungs 
from CXCR3-/- and WT mice (magnification ×40); the arrow points to the 
enlarged airspace in WT mice.  n=8 mice/group.  (B) Difference in Lm 
between CXCR3-/- and WT mice.  Results are expressed as mean±SEM.   
n=6 mice/group, 
cP<0.01.
Table 1.  RT-PCR primers, conditions and products.
  RT-PCR      S/AS      Primer sequence (5′ to 3′)                        Tm    Product 
  Genes                                                                                       (ºC)      (bp)
 
  CXCL9  S  CTTGGGCATCATCTTCCTG  55  352
    AS  TGAACGACGACGACTTTGG 
  CXCL10  S  GTCATTTTCTGCCTCATCC  55  273
    AS  GAGCCCTTTTAGACCTTTT 
  CXCL11  S  CTGCTCAAGGCTTCCTTATGTT  55  166
    AS  CCTTTGTCGTTTATGAGCCTTC 
  TGF-β1  S  CCCTGTATTCCGTCTCCTT  55  363
    AS  GCGGTGCTCGCTTTGTA   
  IFNβ  S  CATCTTGGCTTTGCAGCTCTT  55  363
    AS  CTGGACCTGTGGGTTGTTGA   
  MMP2  S  GTGTCACTGTCCGCCAAA  55  397
    AS  GTCCCGAGACCGCTATGT   
  MMP9  S  AGCCAACTATGACCAGGA  55  367
    AS  TGCCGTCATTGTCGTCTTTAT   
  MMP12  S  GTCCTGGTCTGCCTTCTATC  55  532
    AS  TGTGGAATACTATGGTGGTG   
  TIMP1  S  GCATCTGGCATCCTCTTGTTG  55  637
    AS  GACAGTGTTCAGGCTTCAGTTTTTC   
  TIMP2   S  ACAGGCGTTTTGCAATGCAGAC  55  598
    AS  GCTTTTCAATTGGCCACAGGGGCTC   
  TIMP3  S  CTGGCTTGGGCTTGTCGTGCTCCTGA  55  550
    AS  GGGAAGGAGGTGAGGTGGGGCAGGTC   
  TIMP4  S  CACGCCATTTGACTCTTCCCT  55  485
    AS  CCAGCAGCCAGTCCGTCCAGA   
  β-actin  S  CTTCCTTAATGTCACGCACGATTTC  55  541
    AS  GTGGGGCGGCCCAGGCACCA   
S, sense; AS, antisense439
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of CXCL9 and CXCL11, was significantly up-regulated at three 
days after the last CS exposure in the lung homogenates from 
WT mice relative to CXCR3-/- mice, although the elevation 
of expression of IFNγ mRNA in lung homogenates showed a 
trend towards significance in WT mice at three days after CS 
exposure in comparison to CXCR3 KO mice (P=0.07, Figure 
3B).  More importantly, the concentration of CXCL10 in both 
BAL fluid and lung homogenates was consistently and signifi-
cantly lower in CXCR3 KO mice than in WT mice (BAL fluid: 
19.30±1.36 pg/mL vs 24.82±1.57 pg/mL, P<0.05; lung homo-
genates: 76.6±7.0 pg/mL vs 119.5±15.9 pg/mL, P<0.05) (Figure 
3C).
Airway remodeling is attenuated in CXCR3-/- mice after CS 
exposure
Remodeling of small airways is characterized by thickening 
of airway walls by means of collagen deposition due to aber-
rant repair of tissue
[2].  To investigate the differences in airway 
remodeling in lungs from CXCR3-/- mice and WT mice in 
response to short-term exposure of CS, lung sections stained 
with Masson trichrome were analyzed, and hydroxyproline 
content in lung was measured.  Morphologically, there was 
less pronounced collagen deposition around small airways 
and vessels in CXCR3-/- mice (Figure 4A).  We biochemically 
quantified hydroxyproline content unique to fibrosis in lung 
tissue and found that there was less hydroxyproline content 
in lung homogenates from CXCR3-/- mice than in WT mice 
(6.0±1.0 µg/mL vs 12.0±1.6 µg/mL, P<0.05) (Figure 4B).  To 
further elucidate the possible molecular mechanism underly-
ing the difference in collagen deposition observed between 
CXCR3-/- mice and WT mice, we assayed a fibrogenic 
cytokine, TGFβ1, at the mRNA level in lung homogenates.   
Our data revealed that mRNA expression of TGFβ1 was sig-
nificantly lower in CXCR3-/- mice relative to WT mice at three 
days after the last CS exposure (Figure 4C).
Concentration of protein and TNFα in BAL fluid in CXCR3-/- and 
WT mice
Protein content in BAL fluid, reflecting pulmonary vascular 
permeability into alveolar spaces after the mice were admin-
istered cigarette smoke, was similar between CXCR3-/- mice 
and WT mice (700.9±64.4 µg/mL vs 642.1±97.2 µg/mL) (Fig-
ure 5A).  Also, there was no significant difference in TNFα 
concentration in BAL fluid between CXCR3-/- mice and WT 
mice (20.9±0.9 pg/mL vs 29.4±5.4 pg/mL) (Figure 5B).  There 
was mild infiltration of inflammatory cells, particularly CD8+ 
T cells, in the recovered BAL fluid in both CXCR3-/- mice 
and WT mice; however, there was no significant difference 
between the two genotypes (data not shown).
Figure 2.  Effect of CXCR3 deficiency on mRNA expression of MMPs and 
TIMPs in lung homogenates at three days after the last CS exposure.  (A) 
mRNA expression of MMP2, MMP9, and MMP12 in CXCR3-/- and WT 
mice, n=5 animals/group.  (B) mRNA expression of TIMPs 1-4 in CXCR3-/- 
and WT mice, n=8 animals/group.  Results are expressed as mean±SEM.   
bP<0.05.
Figure 3.  Effect of CXCR3 deletion on mRNA expression in lung 
homogenates and production of CXCL10/IP-10 in BAL fluid and lung 
homogenates at three days after short-term CS exposure.  (A) mRNA 
expression of CXCR3 ligands, n=5 animals/group.  (B) mRNA expression 
of IFNγ, n=6 animals/group.  (C) CXCL10/IP-10 concentration in BAL fluid 
and lung homogenates, n=8 animals/group.  Results are expressed as 
mean±SEM.  
bP<0.05.440
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Discussion
Pulmonary tissue damage represented by enlarged airspace 
in lung tissue has been postulated to result from an imbal-
ance in protease/antiprotease content, in which proteolysis is 
mediated by elastin-degrading enzymes; for example, MMP2, 
MMP9, and MMP12 are over-activated
[22, 24].  MMP12-deficient 
mice were shown to be resistant to developing emphysema 
after long-term CS exposure
[25].  In the current study, we 
found that Lm values, reflecting the enlargement of airspaces, 
were significantly greater in WT mice than in CXCR3-/- mice 
at three days after short-term CS exposure (40.3±2.4 µm vs  
30.1±0.9 µm, P<0.01).  Furthermore, we have observed an 
over-expression of MMP2 and MMP12 at the mRNA level 
at three days after the last CS exposure in WT mice.  This 
reflects inappropriate activation of these enzymes even upon 
short-term CS insult, whereas expression of these enzymes in 
CXCR3-/- mice mRNA was not as high as that in WT mice.   
Under pathological conditions, expression of MMPs is regu-
lated by cytokines and chemokines, which are substrates for 
MMPs.  Previous studies have shown that CXCL10/IP-10 and 
CXCL9/Mig are secreted from lung lymphocytes in patients 
with emphysema, specifically up-regulating MMP12 and thus 
favoring a proteolytic microenvironment that facilitates lung 
destruction
[24, 26].  Elias and colleagues have provided evidence 
that these enzymes may be regulated by proximal immune 
events through a Th1 cell- or IFNγ-dependent manner
[26].  T 
cells, particularly CD8+ T cells, accumulate in the lungs of 
patients with COPD and generate signals such as CXCL10/
IP-10 that promote MMP12 production by macro  phages
[27, 28].   
Moreover, CXCR3 expressed by human T cells and mac-
rophages is required for MMP12 secretion in response to 
IP-10/Mig stimulation
[24].  Our previous data from CXCR3 
knockout mice suggested that attenuated pulmonary acute 
inflammation in CXCR3 knockout mice induced by short-term 
exposure of CS was attributed to lesser recruitment of CD8+ T 
cells into lung tissue and lesser release of its ligand, CXCL10/
IP-10
[15, 16].  Notably, we observed that only CXCL10/IP-10 
remained significantly elevated in both BAL fluid and lung 
homogenates at three days after the last CS exposure (BAL 
fluid: 19.3±1.4 pg/mL vs 24.8±1.6 pg/mL, P<0.05; lung homo-
genates: 76.6±7.0 pg/mL vs 119.5±15.9 pg/mL, P<0.05), and a 
prominent inflammatory response was absent (Figure 1A) in 
this present study.  Therefore, these findings may implicate 
MMPs (MMP2 and MMP12) and effector cytokines (IFNγ and 
CXCL10/IP-10) as potential mediators coordinately driving 
smoking-induced lung destruction.  TIMP3 is the only TIMP 
known to be associated with human diseases
[29] and has an 
inhibitory effect on MMPs.  Mice deficient in TIMP3 dem-
onstrated spontaneous airspace enlargement
[30].  In support 
of the classical view that an imbalance of MMPs and TIMPs 
leads to collagen destruction, we also found that TIMP3 was 
significantly less induced in WT mice compared to CXCR3-/-
mice at the mRNA level.  The exact mechanism of how TIMP3 
expression is regulated by CXCR3 and/or CXCL10 under CS 
challenge remains unclear.
Figure 4.  Effect of CXCR3 on airway remodeling at three days after the 
last CS exposure.  (A) Histological appearance in CXCR3-/- and WT mice 
(magnification ×40); the arrows point to the collagen deposition around 
small airways and vessels in WT mice, n=5 mice/group.  (B) Hydroxyproline 
content of lung tissue in CXCR3-/- and WT mice, n=6 mice/group.  (C) 
Comparison of mRNA expression of TGFβ1 in lung homogenates between 
in CXCR3-/- and WT mice, n=8 mice/group.  Results are expressed as 
mean±SEM.  
bP<0.05.
Figure 5.  Effect of CXCR3 deficiency on protein leakage and TNFα 
concentration in BAL fluid at three days after the three-day CS insult.  (A) 
Protein concentration in BAL fluid, n=5 mice/group.  (B) TNFα content in 
BAL fluid, n=6 mice/group.  Results are expressed as mean±SEM.441
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Airway remodeling is a characteristic of COPD and is asso-
ciated with irreversible airflow limitation
[2].  We have demon-
strated that airway remodeling is less profound in CXCR3-/- 
mice after CS exposure, as reflected by less peribronchial 
deposition of collagen (Figure 4A) and less hydroxyproline 
content in lungs (6.0±1.0 µg/mL vs 12.0±1.6 µg/mL, P<0.05).   
We attempted to explore the mechanism that mediates this 
process.  In this study, we found increased expression of 
TGFβ1 at the mRNA level in WT mice exposed to CS and not 
in CXCR3-/- mice.  The functional importance of TGFβ1 in 
tissue repair has been well described, and it is recognized as 
a potent inducer of collagen production
[31].  Evidence from 
human studies and animal models indicates that TGFβ1 plays 
a pivotal role in mediating pathogenic changes by stimulating 
fibroblasts to synthesize a large amount of extracellular matrix 
proteins.  TGFβ1 is expressed in a variety of cells including 
fibroblasts, macrophages, epithelial, and endothelial cells
[31].   
Although it is generally thought that airway remodeling is due 
to an abnormal response to repeated inflammatory stimulation 
caused by CS and an aberrant repair induced by inflammatory 
cells, it is alternatively accepted that CS directly causes exces-
sive production of growth factors leading to smooth muscle 
hypertrophy and fibrosis formation in the airway, indepen-
dent of the inflammatory response
[31].  Wang and colleagues 
recently reported that elevated TGF1 expression drives air-
way remodeling in tracheal explants even after a single CS 
exposure
[32].  Consistent with these observations, we did not 
demonstrate a significant difference in protein leakage and 
TNFα concentration in BAL fluid between CXCR3-/- and WT 
mice.  Taken together, we carefully put forward the hypoth-
esis that airway remodeling caused by CS challenge could be 
mediated via TGFβ1 released by epithelial cells insulted by CS 
directly.  How TGFβ1 is regulated in the presence of CXCR3 
and CXCL10/IP-10 should be further investigated.
Interactions between MMPs and TGFβ have been suggested 
to explain the contradictory events in destructive pulmonary 
architecture in parenchyma and thickened bronchial walls.  In 
this study, our data demonstrate that over-activation of TGFβ1 
together with MMP2 and MMP12 expression at the mRNA 
level in WT mice, which is partly in accordance with the pre-
vious reports that increased MMPs at the protein level were 
seen in patients with emphysema
[27, 28], have tissue destruc-
tive and fibrotic effects depending on the location (either in 
parenchyma or in airways)
[31].  It should be pointed out that 
the current study was based on a short-term exposure model.   
The exact role of CXCR3 and its ligands in CS-induced chronic 
lung pathology deserves further investigation.
In summary, we have shown that lung tissue destruction 
and airway remodeling are partially, but significantly, allevi-
ated in CXCR3-/- mice at three days after short-term CS expo-
sure.  Our data further show that, possibly independent of an 
inflammatory response, CXCL10/IP-10 in combination with 
MMPs (mainly MMP2 and MMP12) could promote extracel-
lular matrix collagen deposition in the airway, causing subepi-
thelial and lung tissue damage.  This study may suggest that 
early targeting of the CXCR3-CXCL10 axis might be benefi-
cial for halting CS-mediated lung tissue damage and airway 
remodeling.  
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